• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性神经发育障碍的产后治疗方法。

Postnatal therapeutic approaches in genetic neurodevelopmental disorders.

作者信息

Levy Gilad, Barak Boaz

机构信息

The Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.

The Sagol School of Neuroscience; The School of Psychological Sciences, Faculty of Social Sciences, Tel Aviv University, Tel Aviv, Israel.

出版信息

Neural Regen Res. 2021 Mar;16(3):414-422. doi: 10.4103/1673-5374.293133.

DOI:10.4103/1673-5374.293133
PMID:32985459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7996025/
Abstract

Genetic neurodevelopmental disorders are characterized by abnormal neurophysiological and behavioral phenotypes, affecting individuals worldwide. While the subject has been heavily researched, current treatment options relate mostly to alleviating symptoms, rather than targeting the altered genome itself. In this review, we address the neurogenetic basis of neurodevelopmental disorders, genetic tools that are enabling precision research of these disorders in animal models, and postnatal gene-therapy approaches for neurodevelopmental disorders derived from preclinical studies in the laboratory.

摘要

遗传性神经发育障碍的特征是神经生理和行为表型异常,影响着世界各地的个体。尽管该主题已得到大量研究,但目前的治疗选择大多与缓解症状有关,而非针对改变的基因组本身。在本综述中,我们阐述了神经发育障碍的神经遗传学基础、有助于在动物模型中对这些疾病进行精准研究的遗传工具,以及源自实验室临床前研究的神经发育障碍的产后基因治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/298c/7996025/da49758485ab/NRR-16-414-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/298c/7996025/da49758485ab/NRR-16-414-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/298c/7996025/da49758485ab/NRR-16-414-g001.jpg

相似文献

1
Postnatal therapeutic approaches in genetic neurodevelopmental disorders.遗传性神经发育障碍的产后治疗方法。
Neural Regen Res. 2021 Mar;16(3):414-422. doi: 10.4103/1673-5374.293133.
2
CRISPR/Cas9 Technology as a Modern Genetic Manipulation Tool for Recapitulating of Neurodegenerative Disorders in Large Animal Models.CRISPR/Cas9 技术作为一种现代遗传操作工具,用于在大动物模型中重现神经退行性疾病。
Curr Gene Ther. 2021;21(2):130-148. doi: 10.2174/1566523220666201214115024.
3
Animal models of neurodevelopmental disorders with behavioral phenotypes.具有行为表型的神经发育障碍动物模型。
Curr Opin Psychiatry. 2021 Mar 1;34(2):87-93. doi: 10.1097/YCO.0000000000000675.
4
CRISPR/dCas9 as a Therapeutic Approach for Neurodevelopmental Disorders: Innovations and Limitations Compared to Traditional Strategies.CRISPR/dCas9 作为神经发育障碍的治疗方法:与传统策略相比的创新与局限。
Dev Neurosci. 2021;43(3-4):253-261. doi: 10.1159/000515845. Epub 2021 May 3.
5
Advances in CRISPR/Cas9 Genome Editing for the Treatment of Muscular Dystrophies.CRISPR/Cas9 基因组编辑在肌肉疾病治疗中的研究进展。
Hum Gene Ther. 2023 May;34(9-10):388-403. doi: 10.1089/hum.2023.059.
6
Dysregulation of Neurite Outgrowth and Cell Migration in Autism and Other Neurodevelopmental Disorders.自闭症及其他神经发育障碍中神经突生长和细胞迁移的失调
Adv Neurobiol. 2020;25:109-153. doi: 10.1007/978-3-030-45493-7_5.
7
CRISPR-Cas9: A Preclinical and Clinical Perspective for the Treatment of Human Diseases.CRISPR-Cas9:用于治疗人类疾病的临床前和临床视角。
Mol Ther. 2021 Feb 3;29(2):571-586. doi: 10.1016/j.ymthe.2020.09.028. Epub 2020 Sep 20.
8
Reversibility and therapeutic development for neurodevelopmental disorders, insights from genetic animal models.神经发育障碍的可逆转性和治疗开发:遗传动物模型的见解。
Adv Drug Deliv Rev. 2022 Dec;191:114562. doi: 10.1016/j.addr.2022.114562. Epub 2022 Sep 29.
9
Cas9 gene therapy for Angelman syndrome traps Ube3a-ATS long non-coding RNA.Cas9 基因治疗 Angelman 综合征会捕获 Ube3a-ATS 长非编码 RNA。
Nature. 2020 Nov;587(7833):281-284. doi: 10.1038/s41586-020-2835-2. Epub 2020 Oct 21.
10
Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicine.CRISPR/Cas9基因组编辑系统的临床应用:精准医学中的递送方式与挑战
Genes Dis. 2023 Mar 25;11(1):268-282. doi: 10.1016/j.gendis.2023.02.027. eCollection 2024 Jan.

引用本文的文献

1
CRISPR activation for SCN2A-related neurodevelopmental disorders.用于SCN2A相关神经发育障碍的CRISPR激活技术
Nature. 2025 Sep 17. doi: 10.1038/s41586-025-09522-w.
2
Treatability of the KMT2-Associated Neurodevelopmental Disorders Using Antisense Oligonucleotide-Based Treatments.使用基于反义寡核苷酸的疗法治疗与KMT2相关的神经发育障碍
Hum Mutat. 2024 May 29;2024:9933129. doi: 10.1155/2024/9933129. eCollection 2024.
3
Polymeric nanocarriers for therapeutic gene delivery.用于治疗性基因递送的聚合物纳米载体。

本文引用的文献

1
BMAL1 knockout macaque monkeys display reduced sleep and psychiatric disorders.Bmal1基因敲除的猕猴表现出睡眠减少和精神障碍。
Natl Sci Rev. 2019 Jan;6(1):87-100. doi: 10.1093/nsr/nwz002. Epub 2019 Jan 24.
2
Resolving the Synaptic versus Developmental Dichotomy of Autism Risk Genes.解决自闭症风险基因的突触与发育二分法问题。
Trends Neurosci. 2020 Apr;43(4):227-241. doi: 10.1016/j.tins.2020.01.009. Epub 2020 Feb 22.
3
Whole brain delivery of an instability-prone transgene improves behavioral and molecular pathological defects in mouse models of Rett syndrome.
Asian J Pharm Sci. 2025 Feb;20(1):101015. doi: 10.1016/j.ajps.2025.101015. Epub 2025 Jan 4.
4
PROs for RARE: protocol for development of a core patient reported outcome set for individuals with genetic intellectual disability.罕见病 PROs 研究:用于制定针对遗传性智力障碍患者的核心患者报告结局集的方案。
Orphanet J Rare Dis. 2024 Sep 27;19(1):354. doi: 10.1186/s13023-024-03264-0.
5
Navigating the outcome maze: a scoping review of outcomes and instruments in clinical trials in genetic neurodevelopmental disorders and intellectual disability.探索结果迷宫:对遗传神经发育障碍和智力残疾临床试验中的结果与工具的范围综述
Ther Adv Rare Dis. 2024 Apr 25;5:26330040241245721. doi: 10.1177/26330040241245721. eCollection 2024 Jan-Dec.
6
Deletion of via Systemic Administration of AAV-PHP.eB Virus Increases Social Behavior in a Mouse Model of a Neurodevelopmental Disorder.通过全身注射AAV-PHP.eB病毒缺失基因可增加神经发育障碍小鼠模型的社交行为。
Biomedicines. 2023 Aug 15;11(8):2273. doi: 10.3390/biomedicines11082273.
7
Williams syndrome.威廉姆斯综合征。
Nat Rev Dis Primers. 2021 Jun 17;7(1):42. doi: 10.1038/s41572-021-00276-z.
8
Clinical and Neurobiological Aspects of TAO Kinase Family in Neurodevelopmental Disorders.神经发育障碍中TAO激酶家族的临床和神经生物学方面
Front Mol Neurosci. 2021 Mar 24;14:655037. doi: 10.3389/fnmol.2021.655037. eCollection 2021.
全脑递送不稳定易位转基因可改善 Rett 综合征小鼠模型的行为和分子病理学缺陷。
Elife. 2020 Mar 24;9:e52629. doi: 10.7554/eLife.52629.
4
Efficient generation of Knock-in/Knock-out marmoset embryo via CRISPR/Cas9 gene editing.通过 CRISPR/Cas9 基因编辑高效生成基因敲入/敲除狨猴胚胎。
Sci Rep. 2019 Sep 3;9(1):12719. doi: 10.1038/s41598-019-49110-3.
5
Atypical behaviour and connectivity in SHANK3-mutant macaques.SHANK3 基因突变猕猴的异常行为和连通性。
Nature. 2019 Jun;570(7761):326-331. doi: 10.1038/s41586-019-1278-0. Epub 2019 Jun 12.
6
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioral and myelin alterations rescuable by a remyelinating drug.神经元中 Gtf2i 的缺失与威廉姆斯综合征有关,可导致行为和髓鞘改变,一种髓鞘修复药物可对此进行挽救。
Nat Neurosci. 2019 May;22(5):700-708. doi: 10.1038/s41593-019-0380-9. Epub 2019 Apr 22.
7
Nanoparticle delivery of CRISPR into the brain rescues a mouse model of fragile X syndrome from exaggerated repetitive behaviours.纳米颗粒介导的 CRISPR 递送至大脑可挽救脆性 X 综合征小鼠模型的过度重复行为。
Nat Biomed Eng. 2018 Jul;2(7):497-507. doi: 10.1038/s41551-018-0252-8. Epub 2018 Jun 25.
8
Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality.治疗性 AAV 基因向神经系统的转移:临床现实。
Neuron. 2019 Mar 6;101(5):839-862. doi: 10.1016/j.neuron.2019.02.017.
9
Design of AAV Vectors for Delivery of Large or Multiple Transgenes.用于递送大基因或多个转基因的腺相关病毒载体设计
Methods Mol Biol. 2019;1950:19-33. doi: 10.1007/978-1-4939-9139-6_2.
10
Gene Transfer with AAV9-PHP.B Rescues Hearing in a Mouse Model of Usher Syndrome 3A and Transduces Hair Cells in a Non-human Primate.利用AAV9-PHP.B进行基因转移可挽救3A型Usher综合征小鼠模型的听力并转导非人灵长类动物的毛细胞。
Mol Ther Methods Clin Dev. 2018 Nov 20;13:1-13. doi: 10.1016/j.omtm.2018.11.003. eCollection 2019 Jun 14.